The International Prognostic Index in aggressive B-cell lymphoma von Maurer, Matthew J.

Volltext

Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214 von Escudier, Bernard, Motzer, Robert J., Tannir, Nizar M., Porta, Camillo, Tomita, Yoshihiko, Maurer, Matthew A., McHenry, M. Brent, Rini, Brian I.

Volltext

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study von Crump, Michael, Neelapu, Sattva S., Farooq, Umar, Van Den Neste, Eric, Kuruvilla, John, Westin, Jason, Link, Brian K., Hay, Annette, Cerhan, James R., Zhu, Liting, Boussetta, Sami, Feng, Lei, Maurer, Matthew J., Navale, Lynn, Wiezorek, Jeff, Go, William Y., Gisselbrecht, Christian

Volltext

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the N... von Casulo, Carla, Byrtek, Michelle, Dawson, Keith L, Zhou, Xiaolei, Farber, Charles M, Flowers, Christopher R, Hainsworth, John D, Maurer, Matthew J, Cerhan, James R, Link, Brian K, Zelenetz, Andrew D, Friedberg, Jonathan W

Volltext

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma von Choueiri, Toni K, Powles, Thomas, Burotto, Mauricio, Escudier, Bernard, Bourlon, Maria T, Zurawski, Bogdan, Oyervides Juárez, Victor M, Hsieh, James J, Basso, Umberto, Shah, Amishi Y, Suárez, Cristina, Hamzaj, Alketa, Goh, Jeffrey C, Barrios, Carlos, Richardet, Martin, Porta, Camillo, Kowalyszyn, Rubén, Feregrino, Juan P, Żołnierek, Jakub, Pook, David, Kessler, Elizabeth R, Tomita, Yoshihiko, Mizuno, Ryuichi, Bedke, Jens, Zhang, Joshua, Maurer, Matthew A, Simsek, Burcin, Ejzykowicz, Flavia, Schwab, Gisela M, Apolo, Andrea B, Motzer, Robert J

Volltext

POD24 in MZL: a means to an end or an end point in itself? von Maurer, Matthew J.

Volltext

Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts von Sarkozy, Clémentine, Maurer, Matthew J, Link, Brian K, Ghesquieres, Hervé, Nicolas, Emmanuelle, Thompson, Carrie A, Traverse-Glehen, Alexandra, Feldman, Andrew L, Allmer, Cristine, Slager, Susan L, Ansell, Stephen M, Habermann, Thomas M, Bachy, Emmanuel, Cerhan, James R, Salles, Gilles

Volltext

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy von Bachy, Emmanuel, Maurer, Matthew J., Habermann, Thomas M., Gelas-Dore, Bénédicte, Maucort-Boulch, Delphine, Estell, Jane A., Van den Neste, Eric, Bouabdallah, Réda, Gyan, Emmanuel, Feldman, Andrew L., Bargay, Joan, Delmer, Alain, Slager, Susan L., Gomes da Silva, Maria, Fitoussi, Olivier, Belada, David, Maisonneuve, Hervé, Intragumtornchai, Tanin, Ansell, Stephen M., Lamy, Thierry, Dartigues, Peggy, Link, Brian K., Seymour, John F., Cerhan, James R., Salles, Gilles

Volltext

Non‐Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011 von Al‐Hamadani, Mohammed, Habermann, Thomas M., Cerhan, James R., Macon, William R., Maurer, Matthew J., Go, Ronald S.

Volltext

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation von Xing, Yan, Lin, Nancy U, Maurer, Matthew A, Chen, Huiqin, Mahvash, Armeen, Sahin, Aysegul, Akcakanat, Argun, Li, Yisheng, Abramson, Vandana, Litton, Jennifer, Chavez-MacGregor, Mariana, Valero, Vicente, Piha-Paul, Sarina A, Hong, David, Do, Kim-Anh, Tarco, Emily, Riall, Dianna, Eterovic, Agda Karina, Wulf, Gerburg M, Cantley, Lewis C, Mills, Gordon B, Doyle, L Austin, Winer, Eric, Hortobagyi, Gabriel N, Gonzalez-Angulo, Ana Maria, Meric-Bernstam, Funda

Volltext

Engineering Rhodosporidium toruloides for increased lipid production von Zhang, Shuyan, Skerker, Jeffrey M., Rutter, Charles D., Maurer, Matthew J., Arkin, Adam P., Rao, Christopher V.

Volltext

Reversing the restrictive trend in diffuse large B‐cell lymphoma trial eligibility: it’s time to open the gates von Khurana, Arushi, Maurer, Matthew J.

Volltext

ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients von Sibon, David, Nguyen, Dinh-Phong, Schmitz, Norbert, Suzuki, Ritsuro, Feldman, Andrew L, Gressin, Rémy, Lamant, Laurence, Weisenburger, Dennis D, Rosenwald, Andreas, Nakamura, Shigeo, Ziepert, Marita, Maurer, Matthew J, Bast, Martin, Armitage, James O, Vose, Julie M, Tilly, Hervé, Jais, Jean-Philippe, Savage, Kerry J

Volltext

The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer von Serebrenik, Artur A, Argyris, Prokopios P, Jarvis, Matthew C, Brown, William L, Bazzaro, Martina, Vogel, Rachel I, Erickson, Britt K, Lee, Sun-Hee, Goergen, Krista M, Maurer, Matthew J, Heinzen, Ethan P, Oberg, Ann L, Huang, Yajue, Hou, Xiaonan, Weroha, S John, Kaufmann, Scott H, Harris, Reuben S

Volltext

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303 von Bartlett, Nancy L, Wilson, Wyndham H, Jung, Sin-Ho, Hsi, Eric D, Maurer, Matthew J, Pederson, Levi D, Polley, Mei-Yin C, Pitcher, Brandelyn N, Cheson, Bruce D, Kahl, Brad S, Friedberg, Jonathan W, Staudt, Louis M, Wagner-Johnston, Nina D, Blum, Kristie A, Abramson, Jeremy S, Reddy, Nishitha M, Winter, Jane N, Chang, Julie E, Gopal, Ajay K, Chadburn, Amy, Mathew, Susan, Fisher, Richard I, Richards, Kristy L, Schöder, Heiko, Zelenetz, Andrew D, Leonard, John P

Volltext

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer von Galanis, Evanthia, Atherton, Pamela J, Maurer, Matthew J, Knutson, Keith L, Dowdy, Sean C, Cliby, William A, Haluska, Jr, Paul, Long, Harry J, Oberg, Ann, Aderca, Ileana, Block, Matthew S, Bakkum-Gamez, Jamie, Federspiel, Mark J, Russell, Stephen J, Kalli, Kimberly R, Keeney, Gary, Peng, Kah Whye, Hartmann, Lynn C

Volltext

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials von Maurer, Matthew J, Ghesquières, Hervé, Link, Brian K, Jais, Jean-Philippe, Habermann, Thomas M, Thompson, Carrie A, Haioun, Corinne, Allmer, Cristine, Johnston, Patrick B, Delarue, Richard, Micallef, Ivana N, Peyrade, Frederic, Inwards, David J, Ketterer, Nicolas, Farooq, Umar, Fitoussi, Olivier, Macon, William R, Molina, Thierry J, Syrbu, Sergei, Feldman, Andrew L, Slager, Susan L, Weiner, George J, Ansell, Stephen M, Cerhan, James R, Salles, Gilles A, Witzig, Thomas E, Tilly, Hervé, Nowakowski, Grzegorz S

Volltext

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence... von LINK, Brian K, MAURER, Matthew J, COLGAN, Joseph P, WITZIG, Thomas E, HABERMANN, Thomas M, CERHAN, James R, NOWAKOWSKI, Grzegorz S, ANSELL, Stephen M, MACON, William R, SYRBU, Sergei I, SLAGER, Susan L, THOMPSON, Carrie A, INWARDS, David J, JOHNSTON, Patrick B

Volltext

Selection of chromosomal DNA libraries using a multiplex CRISPR system von Ryan, Owen W, Skerker, Jeffrey M, Maurer, Matthew J, Li, Xin, Tsai, Jordan C, Poddar, Snigdha, Lee, Michael E, DeLoache, Will, Dueber, John E, Arkin, Adam P, Cate, Jamie H D

Volltext

Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium von Wang, Yucai, Jain, Preetesh, Locke, Frederick L, Maurer, Matthew J, Frank, Matthew J, Munoz, Javier L, Dahiya, Saurabh, Beitinjaneh, Amer M, Jacobs, Miriam T, Mcguirk, Joseph P, Vose, Julie M, Goy, Andre, Andreadis, Charalambos, Hill, Brian T, Dorritie, Kathleen A, Oluwole, Olalekan O, Deol, Abhinav, Paludo, Jonas, Shah, Bijal, Wang, Trent, Banerjee, Rahul, Miklos, David B, Rapoport, Aaron P, Lekakis, Lazaros, Ghobadi, Armin, Neelapu, Sattva S, Lin, Yi, Wang, Michael L, Jain, Michael D

Volltext